Targeting Slit-Roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis

Cancer Science

Volumn 99, Issue 3, 2008, Pages 510-517

  Wang, Li Jing ^a,c   Zhao, Yuan ^a   Han, Bing ^e   Ma, Yu Guang ^a   Zhang, Jie ^a   Yang, Ding Ming ^f   Mao, Jian Wen ^c   Tang, Fu Tian ^c   Li, Wei Dong ^c   Yang, Yang ^c   Wang, Rui ^a   Geng, Jian Guo ^b,d  

^a LANZHOU UNIVERSITY   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e Institute of Electron Material   (China)

^f Shiel Medical Diagnostic Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANGIOGENESIS INHIBITOR; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY R5; ROUNDABOUT RECEPTOR; SLIT PROTEIN; SLIT2 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CHEEK MUCOSA; CHEEK POUCH; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; HAMSTER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION;

EID: 38949206522     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00721.x     Document Type: Article

References (49)

1. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-64.
2. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005; 438: 932-6.
3. Carmeliet P, Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature 2005; 436: 193-200.
4. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
5. Holash J, Thurston G, Rudge JS et al. Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents. Cancer Metastasis Rev 2006; 25: 243-52.
6. Folkman J. Angiogenesis: An organizing principle for drug discovery? Nat Rev Drug Discov 2007; 6: 273-86.
7. Folkman J. Angiogenesis. Annu Rev Med 2006; 57: 1-18.
8. Ferrara N. Role of vascular endothelial growth factor physiologic and pathologic angiogenesis: Therapeutic implications. Semin Oncol 2002; 29: 10-14.
9. Itoh A, Miyabayashi T, Sakano S et al. Cloning and expression of three mammalian homologues of Drosophila slit suggest possible roles of Slit in the formation and maintenance of the nervous system. Mol Brain Res 1998; 62: 175-86.
10. Wong K, Park HT, Wu JY, Rao Y. Slit proteins: Molecular guidance cues for cells ranging from neurons to leukocytes. Curr Opin Genet Dev 2002; 12: 583-91.
11. Wu W, Wong K, Chen JH et al. Directional guidance of neuronal migration in the olfactory system by the protein Slit. Nature 1999; 400: 331-6.
12. Wu JY, Feng L, Park HT et al. Slit, a molecule known to guide axon projection and neuronal migration, inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 2001; 410: 948-52.
13. Piper M, Georgas K, Yamada T, Little M. Expression of the vertebrate Slit gene family and their putative receptors, the Robo genes, in the developing murine kidney. Mech Dev 2000; 94: 213-17.
14. Marillat V, Cases O, Nguyen-Ba-Charvet KT, Tessier-Lavigne M, Sotelo C, Chedotal A. Spatiotemporal expression patterns of slit and robo genes in the rat brain. J Comp Neurol 2002; 442: 130-55.
15. Stein E, Tessier-Lavigne M. Hierarchical organization of guidance receptors: Silencing of netrin attraction by slit through a Robo/DCC receptor complex. Science 2001; 291: 1928-38.
16. Huminiecki L, Gorn M, Suchting S, Poulsom R, Bicknell R. Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis. Genomics 2002; 79: 547-52.
17. Wong K, Ren XR, Huang YZ et al. Signal transduction in neuronal migration: Roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell 2001; 107: 209-21.
18. Park KW, Morrison CM, Sorenson LK et al. Robo4 is a vascular-specific receptor that inhibits endothelial migration. Dev Bio 2003; 261: 251-67.
19. Kidd T, Brose K, Mitchell KJ et al. Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors. Cell 1998; 92: 201-15.
20. Brose K, Bland KS, Wang KH et al. Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell 1999; 96: 795-806.
21. Wang KH, Brose K, Arnott D et al. Biochemical purification of a mammalian slit protein as a positive regulator of sensory axon elongation and branching. Cell 1999; 96: 771-84.
22. Li HS, Chen JH, Wu W et al. Vertebrate Slit, a secreted ligand for the transmembrane protein roundabout, is a repellent for olfactory bulb axons. Cell 1999; 96: 807-18.
23. Whitford KL, Marillat V, Stein E et al. Regulation of cortical dendrite development by Slit-Robo interactions. Neuron 2002; 33: 47-61.
24. Wang B, Xiao Y, Ding BB et al. Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell 2003; 4: 19-29.
25. Kaur S, Castellone MD, Bedell VM, Konar M, Gutkind JS, Ramchandran R. Robo 4 signaling in endothelial cells implies attraction guidance mechanisms. J Biol Chem 2006; 281: 11.347-56.
26. Bedell VM, Yeo SY, Park KW et al. Roundabout 4 is essential for angiogenesis in vivo. Proc Natl Acad Sci USA 2005; 102: 6373-8.
27. Salley JJ. Experimental carcinogenesis in the cheek pouch of the Syrian hamster. J Dent Res 1954; 33: 253-62.
28. Gimenez-Conti IB, Slaga TJ. The hamster cheek pouch carcinogenesis model. J Cell Biochem Suppl 1993; 17F: 83-90.
29. Li N, Chen X, Liao J et al. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis hamsters by tea and curcumin. Carcinogenesis 2002; 23: 1307-13.
30. Chang KW, Sarraj S, Lin SC, Tsai PI, Solt D. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis 2000; 21: 1441-51.
31. Kohno Y, Patel V, Kim Y et al. Apoptosis, proliferation and p12 (doc-1) profiles in normal, dysplastic and malignant squamous epithelium of the Syrian hamster cheek pouch model. Oral Oncol 2002; 38: 274-80.
32. Chen YK, Huse SS, Lin LM. Inhibitory effect of inducible nitric oxide synthase inhibitor on DMBA-induced hamster buccal-pouch squamous-cell carcinogenesis. Nitric Oxide 2005; 13: 232-9.
33. Chan T, Burggren W. Hypoxic incubation creates differential morphological effects during specific developmental critical windows in the embryo of the chicken (Gallus gallus) Respir Physiol Neurobiol 2005; 145: 251-63.
34. Pingdborg J, Reichart P, Smith C, van der Wall I, World Health Organization. International Histological Classification of Tumors: Histological Typing of Cancer and Precancer of Oral Mucosa, 2nd edn. Berlin: Springer, 1997.
35. Yoshida K, Hirose Y, Tanaka T et al. Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor γ ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide. Cancer Sci 2003; 94: 365-71.
36. Carlile J, Harada K, Baillie R et al. Vascular endothelial growth factor (VEGF) expression in oral tissues: Possible relevance to angiogenesis, tumour progression and field cancerisation. J Oral Pathol Med 2001; 30: 449-57.
37. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
38. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
39. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT. Presentation, treatment, and outcome of oral cavity cancer: A National Cancer Data Base report. Head Neck 2002; 24: 165-80.
40. Jemal A, Tiwari RC, Murray T et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54: 8-29.
41. Davies L, Welch HG. Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg 2006; 135: 451-7.
42. Dallol A, Da Silva NF, Viacava P et al. SLIT2, a human homologue drosophila Slit2 gene, has tumor suppressor activity is frequently inactivated lung breast cancers. Cancer Res 2002; 62: 5874-80.
43. Dallol A, Morton D, Maher ER, Latif F. SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res 2003; 63: 1054-8.
44. Latil A, Chene L, Cochant-Priollet B et al. Quantification of expression of netrins, slits and their receptors in human prostate tumors. Int J Cancer 2003; 103: 306-15.
45. Klagsbrun M, Eichmann A. A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev 2005; 16: 535-48.
46. Fujiwara M, Ghazizadeh M, Kawanami O. Potential role of the Slit/Robo signal pathway in angiogenesis. Vasc Med 2006; 11: 115-21.
47. Arora S, Kaur J, Sharma C et al. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: Correlation with microvessel density, progression, and prognosis. Clin Cancer Res 2005; 11: 2272-84.
48. Casanovas O, Hicklin DJ, Berqers G, Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 2005; 8: 299-309.
49. Hurwitz H, Fehrenbacher L, Novotny W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-42.